Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 9645

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.11, p 0.778). This receipt's hash covers every field on it, plus the hash of receipt 9644, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 9645
    25 Oct 2026, 10:38 UTC

    CEBPZ

    dopamine neurons, braak

    predictionCEBPZ in dopamine neurons tracks Braak Lewy-body stage

    registeredcd3c6a2283addb8e

    discovery-0.11 p=0.778 n=9

    replication+0.20 p=0.613 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.11, p 0.778)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    03764a37e95263fda02c14dc…
    follows 694cf28687e4…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 9645: CEBPZ in dopamine neurons, braak

power
full sample +0.12 (p 0.646, n 18), 95% CI -0.37 to +0.55. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.18 (p 0.471, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.11 (p 0.677, n 18). could be the mix.
skeptic
leave-one-out range +0.01 to +0.20, sign flips 0; without severely affected donors +0.12 (p 0.646, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for CEBPZ in dopamine neurons.

case closed: nothing better to follow up.